Terms: = Ovarian cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG
54 results:
1. All-cause and cancer-specific mortality after fertility-sparing surgery for stage IA and IC epithelial ovarian cancer.
Jorgensen K; Denham C; Kanbergs A; Wu CF; Nitecki R; Agusti N; Meernik C; Melamed A; Rauh-Hain JA
Gynecol Oncol; 2023 Nov; 178():60-68. PubMed ID: 37801736
[TBL] [Abstract] [Full Text] [Related]
2. Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.
Wu M; Tang Q; Cai S; Zhu L; Lin C; Guan Y; Rao S; Zhou J
Eur J Radiol; 2023 Feb; 159():110670. PubMed ID: 36584564
[TBL] [Abstract] [Full Text] [Related]
3. Loss of Major Histocompatibility Complex Class I, CD8 + Tumor-infiltrating Lymphocytes, and PD-L1 Expression in ovarian Clear Cell Carcinoma.
Lin SY; Hang JF; Lai CR; Chan IS; Shih YC; Jiang LY; Chang YH; Chen YJ
Am J Surg Pathol; 2023 Jan; 47(1):124-130. PubMed ID: 36221308
[TBL] [Abstract] [Full Text] [Related]
4. Better or worse? The prognostic role of the mesenchymal subtype in patients with high-grade serous ovarian carcinoma: A systematic review and meta-analysis.
Chen J; Shi X; Xiao L; Li Z; Li Z; Sun L
Cancer Med; 2022 Oct; 11(20):3761-3770. PubMed ID: 35434908
[TBL] [Abstract] [Full Text] [Related]
5. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
[TBL] [Abstract] [Full Text] [Related]
6. Pre-treatment sarcopenic assessments as a prognostic factor for gynaecology cancer outcomes: systematic review and meta-analysis.
Sutton EH; Plyta M; Fragkos K; Di Caro S
Eur J Clin Nutr; 2022 Nov; 76(11):1513-1527. PubMed ID: 35194194
[TBL] [Abstract] [Full Text] [Related]
7. The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic
Odintsov I; Lui AJW; Sisso WJ; Gladstone E; Liu Z; Delasos L; Kurth RI; Sisso EM; Vojnic M; Khodos I; Mattar MS; de Stanchina E; Leland SM; Ladanyi M; Somwar R
Clin Cancer Res; 2021 Jun; 27(11):3154-3166. PubMed ID: 33824166
[TBL] [Abstract] [Full Text] [Related]
8. Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis.
Lee CK; Friedlander ML; Tjokrowidjaja A; Ledermann JA; Coleman RL; Mirza MR; Matulonis UA; Pujade-Lauraine E; Bloomfield R; Goble S; Wang P; Glasspool RM; Scott CL;
Cancer; 2021 Jul; 127(14):2432-2441. PubMed ID: 33740262
[TBL] [Abstract] [Full Text] [Related]
9. Preoperative serum CA-125 level as a predictor for the extent of cytoreduction in patients with advanced stage epithelial ovarian cancer.
Merlo S; Besic N; Drmota E; Kovacevic N
Radiol Oncol; 2021 Aug; 55(3):341-346. PubMed ID: 33675192
[TBL] [Abstract] [Full Text] [Related]
10. The timing of venous thromboembolism in ovarian cancer patients: A nationwide Danish cohort study.
Strøm Kahr H; Christiansen OB; Juul Riddersholm S; Gade IL; Torp-Pedersen C; Knudsen A; Thorlacius-Ussing O
J Thromb Haemost; 2021 Apr; 19(4):992-1000. PubMed ID: 33420762
[TBL] [Abstract] [Full Text] [Related]
11. Identification of novel prognosis-related genes in the endometrial cancer immune microenvironment.
Ma J; Zhang JK; Yang D; Ma XX
Aging (Albany NY); 2020 Nov; 12(21):22152-22173. PubMed ID: 33159014
[TBL] [Abstract] [Full Text] [Related]
12. Meta-analysis based gene expression profiling reveals functional genes in ovarian cancer.
Zhao L; Li Y; Zhang Z; Zou J; Li J; Wei R; Guo Q; Zhu X; Chu C; Fu X; Yue J; Li X
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33135729
[TBL] [Abstract] [Full Text] [Related]
13. Nuclear Atypia Is a Necessary Factor for Diagnosis of Primary ovarian Fibrosarcoma: A Case Report and Literature Review.
Zhang Z; Yao A; Xin Q; Shi Y; Zhang A
Gynecol Obstet Invest; 2020; 85(5):437-445. PubMed ID: 33011729
[TBL] [Abstract] [Full Text] [Related]
14. Clinical Significance of Annexin A4 as a Biomarker in the Early Diagnosis of Hepatocellular Carcinoma.
Saad ZM; Fouad Y; Ali LH; Hassanin TM
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2661-2665. PubMed ID: 32986366
[TBL] [Abstract] [Full Text] [Related]
15. Risk of primary urological and genital cancers following incident breast cancer: a Danish population-based cohort study.
Sundbøll J; Farkas DK; Adelborg K; Schapira L; Tamang S; Nørgaard M; Cullen MR; Cronin-Fenton D; Sørensen HT
Breast Cancer Res Treat; 2020 Dec; 184(3):825-837. PubMed ID: 32845432
[TBL] [Abstract] [Full Text] [Related]
16. Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial.
Konstantinopoulos PA; Cheng SC; Wahner Hendrickson AE; Penson RT; Schumer ST; Doyle LA; Lee EK; Kohn EC; Duska LR; Crispens MA; Olawaiye AB; Winer IS; Barroilhet LM; Fu S; McHale MT; Schilder RJ; Färkkilä A; Chowdhury D; Curtis J; Quinn RS; Bowes B; D'Andrea AD; Shapiro GI; Matulonis UA
Lancet Oncol; 2020 Jul; 21(7):957-968. PubMed ID: 32553118
[TBL] [Abstract] [Full Text] [Related]
17. Mechanistically derived patient-level framework for precision medicine identifies a personalized immune prognostic signature in high-grade serous ovarian cancer.
Zhao H; Gu S; Bao S; Yan C; Zhang Z; Hou P; Zhou M; Sun J
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32436954
[TBL] [Abstract] [Full Text] [Related]
18. Incidence and risk factors of preoperative venous thromboembolism and pulmonary embolism in patients with ovarian cancer.
Liang S; Tang W; Ye S; Xiang L; Wu X; Yang H
Thromb Res; 2020 Jun; 190():129-134. PubMed ID: 32361343
[TBL] [Abstract] [Full Text] [Related]
19. Johannesburg cancer Study (JCS): contribution to knowledge and opportunities arising from 20 years of data collection in an African setting.
Chen WC; Singh E; Muchengeti M; Bradshaw D; Mathew CG; Babb de Villiers C; Lewis CM; Waterboer T; Newton R; Sitas F
Cancer Epidemiol; 2020 Apr; 65():101701. PubMed ID: 32169796
[TBL] [Abstract] [Full Text] [Related]
20. Development and validation of a model that includes two ultrasound parameters and the plasma D-dimer level for predicting malignancy in adnexal masses: an observational study.
Stukan M; Badocha M; Ratajczak K
BMC Cancer; 2019 Jun; 19(1):564. PubMed ID: 31185938
[TBL] [Abstract] [Full Text] [Related]
[Next]
